Cargando…

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis

Obesity, insulin resistance, and diabetes are strongly linked to the accumulation of excessive lipids in the liver parenchyma, a condition known as nonalcoholic fatty liver disease (NAFLD). Given its association with obesity and related metabolic diseases, it is not surprising that the prevalence of...

Descripción completa

Detalles Bibliográficos
Autor principal:	Finck, Brian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245219/ https://www.ncbi.nlm.nih.gov/pubmed/30459251 http://dx.doi.org/10.2337/dbi18-0024

Ejemplares similares

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

The polarizable and reprogrammable identity of Kupffer cells in Nonalcoholic Steatohepatitis
por: Zahr, Tarik, et al.
Publicado: (2022)

MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
por: Fernandez-Valverde, Selene L., et al.
Publicado: (2011)

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
por: Brennan, Paul N., et al.
Publicado: (2023)

Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
por: Bender, Shawn B., et al.
Publicado: (2013)

Acylcarnitines: Reflecting or Inflicting Insulin Resistance?
por: Schooneman, Marieke G., et al.
Publicado: (2013)

Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
por: Karpe, Fredrik, et al.
Publicado: (2011)

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
por: Bozadjieva, Nadejda, et al.
Publicado: (2018)

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
por: Neel, Brian A., et al.
Publicado: (2011)

Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program
por: Williams, RN, et al.
Publicado: (2016)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Diabetic Retinopathy: Targeting Vasoregression
por: Hammes, Hans-Peter, et al.
Publicado: (2011)

Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of Hepatotoxicity
por: Guturu, Praveen, et al.
Publicado: (2012)

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
por: Hartman, Mark L., et al.
Publicado: (2020)

Nutrient-Sensing Mechanisms in the Gut as Therapeutic Targets for Diabetes
por: Breen, Danna M., et al.
Publicado: (2013)

The regulatory state of nonalcoholic steatohepatitis and metabolism
por: Omokaro, Stephanie O., et al.
Publicado: (2020)

Closing in on the Mechanisms of Pulsatile Insulin Secretion
por: Bertram, Richard, et al.
Publicado: (2018)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

The Complex Mechanism of Glutamate Dehydrogenase in Insulin Secretion
por: Fahien, Leonard A., et al.
Publicado: (2011)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

SUN-694 Case Study of Nonalcoholic Steatohepatitis Reversibility in Type Two Diabetic Patient with Weight Loss Using Liraglutide
por: Shaghouli, Amna Ali, et al.
Publicado: (2020)

AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
por: Hardie, D. Grahame
Publicado: (2013)

Learning From Past Failures of Oral Insulin Trials
por: Michels, Aaron W., et al.
Publicado: (2018)

Insulin Regulates Brain Function, but How Does It Get There?
por: Gray, Sarah M., et al.
Publicado: (2014)

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
por: Lomonaco, Romina, et al.
Publicado: (2016)

Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes
por: Naegeli, A N, et al.
Publicado: (2010)

Direct Autocrine Action of Insulin on β-Cells: Does It Make Physiological Sense?
por: Rhodes, Christopher J., et al.
Publicado: (2013)

Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis
por: Soeda, Kotaro, et al.
Publicado: (2023)

HDL as a Biomarker, Potential Therapeutic Target, and Therapy
por: Navab, Mohamad, et al.
Publicado: (2009)

COVID-19–Induced New-Onset Diabetes: Trends and Technologies
por: Metwally, Ahmed A., et al.
Publicado: (2021)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
por: Zhang, Yao, et al.
Publicado: (2022)

Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
por: O’Kell, Allison L., et al.
Publicado: (2017)

New Insights Into Gestational Glucose Metabolism: Lessons Learned From 21st Century Approaches
por: Angueira, Anthony R., et al.
Publicado: (2015)

Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Prolonged remission in latent autoimmune diabetes of adults (LADA): Is insulin resistance a major influence?
por: Rocha, José Vicente, et al.
Publicado: (2023)

β-Cell–Specific Gene Repression: A Mechanism to Protect Against Inappropriate or Maladjusted Insulin Secretion?
por: Schuit, Frans, et al.
Publicado: (2012)

Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer
por: Andersen, Dana K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9d78o1kmkbr8a91371t3pi8q1n